Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Endometrioid × defactinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2 Mesothelioma, Malignant 2 Phase IB 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Endometrioid 1

Interventions

palbociclib 1 defactinib 1 adavosertib 1 Taxes 1 Radiation 1 RO5126766 1 Platinum 1 Paclitaxel 1 Fulvestrant 1 Dasatinib 1 Congresses as Topic 1 Cisplatin 1 Carboplatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03875820 2026-03-10

FRAME

Institute of Cancer Research, United Kingdom

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡